NADEGE SANON: Open Payments
NPI 1740846195 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 19 payments from 14 companies in 2025. Trend: 2023 $1,267 · 2024 $1,493 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $250 |
| ViiV Healthcare Company | 2 | $245 |
| Melinta Therapeutics, LLC | 3 | $222 |
| Aimmune Therapeutics, Inc. | 2 | $140 |
| Astellas Pharma US Inc | 1 | $140 |
| Shionogi Inc | 1 | $121 |
| Novo Nordisk Inc | 1 | $120 |
| Paratek Pharmaceuticals, Inc. | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $119 |
| Exact Sciences Corporation | 1 | $117 |
Products named: CAPLYTA, Rezzayo, Veozah, CABENUVA, Fetroja, Ozempic, APRETUDE, NUZYRA.
Industry payments across FL — which companies pay providers there.
